TME Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Tencent Music Entertainment Group (TME) is not a strong buy at the moment for a beginner investor with a long-term horizon. While the company has shown solid financial performance in Q4 2025, the competitive landscape, particularly from AI-driven platforms like Soda Music, and the recent wave of analyst downgrades suggest significant near-term challenges. The technical indicators and options data do not provide a compelling entry point either. For a long-term investor, it may be prudent to wait for more clarity on the company's ability to navigate competitive pressures and AI disruptions before committing capital.
The MACD is positive at 0.196 but contracting, indicating weakening momentum. RSI is neutral at 29.427, and moving averages are converging, showing no clear trend. The stock is trading near its support level of 9.311, with resistance at 10.125. Overall, technical indicators suggest a neutral stance with no strong buy signal.
Tencent Music's Q4 2025 financials showed strong YoY growth in revenue (15.86%), net income (12.57%), and EPS (12.70%).
The company's gross margin improved to 44.69%, reflecting operational efficiency.
Tencent Music continues to emphasize its dual content-and-platform strategy, which could drive long-term innovation.
Rising competition from AI-driven platforms like Soda Music is pressuring subscription growth and ARPPU.
Analyst downgrades from major firms like Morgan Stanley, UBS, and JPMorgan highlight concerns about Tencent Music's competitive position and growth outlook.
The options market shows bearish sentiment with an Option Volume Put-Call Ratio of 1.55, indicating higher put activity.
No recent significant insider or hedge fund activity to indicate confidence in the stock.
In Q4 2025, Tencent Music delivered strong financial results with revenue of $8.64 billion (up 15.86% YoY), net income of $2.2 billion (up 12.57% YoY), and EPS of $0.71 (up 12.70% YoY). Gross margin improved to 44.69%, up 2.45% YoY. Despite these positives, analysts remain cautious due to competitive pressures.
Recent analyst ratings are overwhelmingly negative. Firms like Morgan Stanley, UBS, and JPMorgan downgraded the stock, citing competitive risks and uncertainties from AI-driven disruptions. Price targets have been significantly reduced, with most analysts setting targets in the $12-$14 range, down from prior targets of $20 or higher. This reflects a cautious outlook on the company's near-term prospects.
